Highland Capital Management (Texas)’s AstraZeneca AZN Stock Holding History

Highland Capital Management (Texas)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$619K	Buy	7,500 +2,500	+50%	+$196K	0.04%	239
2019 Q1	$404K	Buy	+5,000	New	+$394K	0.03%	257
2018 Q4	–	Sell	-15,000	Closed	-$1.19M	–	273
2018 Q3	$1.19M	Buy	15,000 +5,000	+50%	+$378K	0.07%	165
2018 Q2	$702K	Sell	10,000 -10,000	-50%	-$719K	0.04%	179
2018 Q1	$1.4M	Buy	+20,000	New	+$1.39M	0.07%	169
2017 Q1	–	Sell	-210,225	Closed	-$11.5M	–	288
2016 Q4	$11.5M	Sell	210,225 -213,475	-50%	-$12.1M	0.54%	53
2016 Q3	$27.8M	Buy	423,700 +403,700	+2,019%	+$26.4M	0.85%	27
2016 Q2	$1.21M	Sell	20,000 -113,180	-85%	-$6.57M	0.05%	179
2016 Q1	$7.5M	Buy	+133,180	New	+$8M	0.33%	85

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Highland Capital Management (Texas)'s AZN Position: Q2 2019 in Review

Highland Capital Management (Texas) increased its AstraZeneca (AZN) stake by 50% in Q2 2019, buying an estimated $196K and bringing the position to 7,500 shares worth $619K. The position accounts for 0.04% of the portfolio, ranked #239.

Highland Capital Management (Texas) first reported a position in AZN in Q1 2016 and has held it in 9 quarters since. The position peaked at $27.8M in Q3 2016. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Highland Capital Management (Texas) held 7,500 shares of AstraZeneca worth $619K as of Q2 2019.
Highland Capital Management (Texas) bought 2,500 AstraZeneca shares in Q2 2019, an estimated $196K.
AstraZeneca made up 0.04% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #239 holding.
Highland Capital Management (Texas) first reported a position in AstraZeneca in Q1 2016 and has held it in 9 quarters since.
Highland Capital Management (Texas)'s AstraZeneca position peaked at $27.8M in Q3 2016.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.